| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.068 | 0.3 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |